HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jun Shiraishi Selected Research

Intra-Aortic Balloon Pumping

10/2017Rotational Atherectomy Followed by Drug-Coated Balloon Dilation for Left Main In-Stent Restenosis in the Setting of Acute Coronary Syndrome Complicated with Right Coronary Chronic Total Occlusion.
2/2017Primary Percutaneous Coronary Intervention Followed by Valve Surgery for Acute Coronary Syndrome at Left Main Trunk Complicated With Severe Aortic Stenosis.
6/2010Predictors of in-hospital prognosis after primary percutaneous coronary intervention for acute myocardial infarction requiring mechanical support devices.
8/2007In-hospital outcomes of primary percutaneous coronary interventions performed at hospitals with and without on-site coronary artery bypass graft surgery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jun Shiraishi Research Topics

Disease

25Myocardial Infarction
05/2019 - 06/2003
8Thrombosis (Thrombus)
11/2020 - 01/2005
8Infarction (Infarctions)
01/2018 - 06/2003
5Pathologic Constriction (Stenosis)
01/2018 - 04/2009
5Heart Failure
10/2017 - 07/2004
4Thrombocytopenia (Thrombopenia)
06/2019 - 10/2017
3Stroke (Strokes)
06/2022 - 01/2012
3Hemorrhage
06/2021 - 08/2006
3Unstable Angina
01/2019 - 04/2009
3Anemia
01/2018 - 01/2014
3Mucocutaneous Lymph Node Syndrome (Kawasaki Disease)
05/2016 - 01/2011
3Birth Weight (Birth Weights)
08/2015 - 02/2013
3Chronic Renal Insufficiency
01/2014 - 02/2012
3Angina Pectoris
05/2012 - 01/2011
3Necrosis
08/2003 - 05/2002
2Embolism (Embolus)
06/2022 - 10/2016
2Disease Progression
06/2022 - 01/2015
2Muscle Spasticity (Spastic)
12/2020 - 04/2009
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2020 - 05/2012
2Acute Coronary Syndrome
10/2017 - 02/2017
2Atherosclerotic Plaque (Atheroma)
07/2017 - 11/2012
2Aneurysm (Aneurysms)
05/2016 - 01/2011
2Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2016 - 07/2015
2Intestinal Diseases (Diseases, Intestinal)
08/2015 - 02/2013
2Liver Diseases (Liver Disease)
08/2015 - 02/2013
2Rupture
07/2015 - 10/2007
2Neoplasms (Cancer)
01/2015 - 11/2012
2Intestinal Perforation
02/2013 - 12/2011
2Hypertension (High Blood Pressure)
01/2012 - 05/2005
2Cardiovascular Diseases (Cardiovascular Disease)
04/2009 - 05/2006
2Hypoxia (Hypoxemia)
04/2006 - 08/2003
1Atrial Fibrillation
06/2022
1Intracranial Embolism
06/2022
1Ulcer
12/2021
1Cardiac Sudden Death (Sudden Cardiac Arrest)
12/2020
1Essential Thrombocythemia
05/2019
1Pulmonary Hypertension
02/2019
1Respiratory Insufficiency (Respiratory Failure)
02/2019
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2018
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2018
1ST Elevation Myocardial Infarction
10/2017
1Shock
02/2017
1Hypotension (Low Blood Pressure)
02/2017
1Aortic Valve Stenosis (Aortic Stenosis)
02/2017
1Atherosclerosis
05/2016
1Patent Ductus Arteriosus
01/2016
1Pituitary ACTH Hypersecretion
01/2016
1Prolactinoma (Prolactinomas)
01/2016
1Hyperprolactinemia
01/2016
1Bronchopulmonary Dysplasia
07/2015
1Chorioamnionitis
07/2015
1Ureaplasma Infections (Ureaplasma Infection)
04/2015
1Gout
01/2015
1Hyperuricemia
01/2015
1Dyspnea (Shortness of Breath)
01/2015
1Eosinophilia
01/2015

Drug/Important Bio-Agent (IBA)

6Valsartan (Vals)FDA Link
07/2012 - 01/2011
5Pharmaceutical PreparationsIBA
12/2021 - 01/2015
4SteroidsIBA
01/2016 - 02/2003
4Creatine Kinase (Creatine Phosphokinase)IBA
07/2013 - 05/2006
3Angiotensin Receptor AntagonistsIBA
05/2012 - 01/2011
2Nitric Oxide (Nitrogen Monoxide)FDA Link
02/2019 - 04/2006
2Hemoglobins (Hemoglobin)IBA
01/2018 - 10/2017
2MetalsIBA
10/2017 - 02/2017
2EverolimusFDA Link
07/2017 - 10/2016
2CytokinesIBA
01/2015 - 05/2002
2omega-Chloroacetophenone (Mace)IBA
04/2009 - 05/2006
2Glucose (Dextrose)FDA LinkGeneric
04/2006 - 08/2003
2Proteins (Proteins, Gene)FDA Link
04/2006 - 06/2003
2Adenosine Triphosphate (ATP)IBA
08/2003 - 05/2002
1AnticoagulantsIBA
06/2022
1Paclitaxel (Taxol)FDA LinkGeneric
12/2021
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
10/2016
1Clopidogrel (Plavix)FDA Link
10/2016
1Warfarin (Coumadin)FDA LinkGeneric
10/2016
1ProlactinIBA
01/2016
1Dopamine Agonists (Dopamine Agonist)IBA
01/2016
1Hydrocortisone (Cortisol)FDA LinkGeneric
01/2016
1Adrenocorticotropic Hormone (ACTH)FDA Link
01/2016
1LipidsIBA
10/2015
1Surface-Active Agents (Surfactants)IBA
07/2015
1QuinolonesIBA
04/2015
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
01/2015
1InterleukinsIBA
01/2015
1Uric Acid (Urate)IBA
01/2015
1Interleukin-5 (Interleukin 5)IBA
01/2015
1tofisopamIBA
01/2015

Therapy/Procedure

28Percutaneous Coronary Intervention
11/2020 - 01/2005
13Stents
11/2020 - 01/2005
7Therapeutics
06/2022 - 01/2005
5Thrombectomy
10/2016 - 01/2011
4Intra-Aortic Balloon Pumping
10/2017 - 08/2007
3Catheters
07/2017 - 11/2012
2Renal Dialysis (Hemodialysis)
01/2019 - 01/2018
2Coronary Artery Bypass (Coronary Artery Bypass Surgery)
10/2016 - 08/2007
2Parenteral Nutrition
08/2015 - 02/2013
1Secondary Prevention
12/2020
1Implantable Defibrillators (Implantable Cardioverter-Defibrillator)
12/2020
1Drug-Eluting Stents
01/2020
1Conservative Treatment
10/2017